Pediatric Dermatology Clinic now accepting referrals for complex cases
-
May 14, 2026
-
1 min
May 14, 2026
First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.
August 31, 2026
Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.
June 29, 2026